CollPlant, an Israel-based company specializing in regenerative medicine, has reportedly filed a patent in the United States for a 3D bioprinting ink which could be used to print tissues and organs. The bioink is based on CollPlant’s established rhCollagen technology, a proprietary plant-based product used for tissue repair applications.
from 3ders.org - http://www.3ders.org
lunes, 12 de junio de 2017
13:22
MR: EDITOR
John
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation.
Related Posts